Exploratory analysis of serum and urine biomarkers associated with nausea and vomittings induced by highly emetogenic chemotherapy (Biomarker study of TRIPLE)
Phase 3
Completed
- Conditions
- Thoracic tumor
- Registration Number
- JPRN-UMIN000006143
- Lead Sponsor
- Division of thoracic oncology, Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1. patients who registered the TRIPLE study.
2. patients treated at division of thoracic oncology, Shizuoka Cancer Center.
3. all subjects must be able to provide informed,written consent prio to entry.
Exclusion Criteria
None.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method